(Q42909983)

English

Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study

scientific article published on 8 September 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

11 November 2017

Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study (English)

1 reference

Europe PubMed Central

11 November 2017

multiple sclerosis

0 references

relapsing-remitting multiple sclerosis

0 references

1 reference

based on heuristic

inferred from title

Carolyn A. Young

11

1 reference

Europe PubMed Central

11 November 2017

Massimo Filippi

object named as

M Filippi

10

0 references

author name string

G Comi

1

1 reference

Europe PubMed Central

11 November 2017

O Abramsky

2

1 reference

Europe PubMed Central

11 November 2017

T Arbizu

3

1 reference

Europe PubMed Central

11 November 2017

A Boyko

4

1 reference

Europe PubMed Central

11 November 2017

R Gold

5

1 reference

Europe PubMed Central

11 November 2017

E Havrdová

6

1 reference

Europe PubMed Central

11 November 2017

S Komoly

7

1 reference

Europe PubMed Central

11 November 2017

K Selmaj

8

1 reference

Europe PubMed Central

11 November 2017

B Sharrack

9

1 reference

Europe PubMed Central

11 November 2017

publication date

8 September 2010

1 reference

Europe PubMed Central

11 November 2017

Multiple Sclerosis Journal

1 reference

Europe PubMed Central

11 November 2017

16

1 reference

Europe PubMed Central

11 November 2017

11

1 reference

Europe PubMed Central

11 November 2017

1360-1366

1 reference

Europe PubMed Central

11 November 2017

Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1177%2F1352458510378127

21 January 2018

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

1 reference

https://api.crossref.org/works/10.1177%2F1352458510378127

21 January 2018

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458510378127

21 January 2018

Treatment with laquinimod reduces development of active MRI lesions in relapsing MS.

1 reference

https://api.crossref.org/works/10.1177%2F1352458510378127

21 January 2018

Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study.

1 reference

https://api.crossref.org/works/10.1177%2F1352458510378127

21 January 2018

Correlation between enhancing lesion number and volume on standard and triple dose gadolinium-enhanced brain MRI scans from patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458510378127

21 January 2018

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458510378127

21 January 2018

Cumulative effect of a weekly low dose of interferon beta 1a on standard and triple dose contrast-enhanced MRI from multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1177%2F1352458510378127

21 January 2018

Identifiers

10.1177/1352458510378127

1 reference

Europe PubMed Central

11 November 2017

1 reference

Europe PubMed Central

11 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42909983&oldid=1973499560"